United Therapeutics Europe Ltd
2 products tracked · names used in filings: United Therapeutics Europe Ltd
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Tyvaso treprostinil sodium | Application withdrawn | |
| 🇪🇺 | Unituxin dinutuximab | Withdrawn | 2015-08-14 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.